We look forward to meeting with you at ASGCT 2023!

VGXI is a leading plasmid DNA contract manufacturer (CDMO) with over 20 years of experience providing high-quality cGMP products to clinical trials worldwide. Applications include DNA vaccines, immunotherapies, and cell and gene therapies.

The company's continuous, low-shear AIRMIX® lysis technology and optimized purification process provide highly supercoiled plasmid with exceptional purity across all manufacturing scales through commercial supply. VGXI's tenured team can also provide flexible solutions tailored to clients' challenging and/or unique project requirements.

Range of Services Provided:

  • Pre-clinical, Highly Documented (HD), and full cGMP plasmid DNA production to support pre-IND through clinical and commercial supply
  • Process Development and Optimization services, Cell Banking, QC release testing, and stability testing 
  • GMP Fill/Finish
  • Pre-clinical through GMP production of RNA products

Brands: VGXI provides pre-clinical through GMP manufacturing services for plasmid DNA and RNA products.